New gel injection could ease knee arthritis pain
NCT ID NCT07516457
First seen Apr 13, 2026 · Last updated Jun 20, 2026 · Updated 12 times
Summary
This study tests a single injection of Hydrogel OA 2% into the knee joint for people with knee osteoarthritis. The goal is to see if it is safe and tolerable. Twenty adults aged 35 to 75 with knee pain will be followed for up to 12 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEO ARTHRITIS OF THE KNEE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
AZ Delta
RECRUITINGRoeselare, Belgium
-
AZ Monica
RECRUITINGDeurne, Belgium
-
AZ Sint Jan
RECRUITINGBruges, Belgium
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Hydrogel OA 2% (a gel injected into the knee joint)
What this could lead to
If it works, this could provide a new option for easing knee osteoarthritis pain with a single injection.
What could go wrong
This is a very small, early safety study with only 20 people. It does not yet prove the gel reduces pain or works better than existing treatments.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.